Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    Glaucine molecular structure

    Glaucine Stats & Data

    PubChem
    MW355.4
    FormulaC21H25NO4
    LogP3.4
    IUPAC(6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline
    InChIKeyRUZIUYOSRDWYQF-HNNXBMFYSA-N
    Chemical Class Aporphine alkaloid
    Psychoactive Class Depressant

    Experience Report Analysis

    Erowid
    8 Reports
    4 Single-substance
    2009–2018 Date Range
    5 With Age Data

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 8 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 6 of 8
    • Not Specified 2 of 8

    Age Distribution

    Reports Over Time

    Real-World Dose Distribution

    Erowid

    From 5 of 5 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=5)

    Median: 160.0mg 25th: 120.0mg 75th: 200.0mg 90th: 200.0mg

    Form / Preparation

    Most common forms and preparations, as a share of the 6 reports that give one

    Too few reports for bars: these forms come from 6 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Capsule 2 of 6
    • Powder / Crystals 2 of 6
    ← Back to Glaucine